Pilot Study, Aimed at Describing in Myography, the Collapse of the Muscular Response Visualized in the Scratch Collapse Test, in Carpal Tunnel Syndrome.
2 other identifiers
interventional
25
1 country
1
Brief Summary
The Scratch Collapse Test (SCT) is a neurocutaneous reflex used to detect peripheral nerve compression in nerve tunnel syndromes. It first involves applying a sensory stimulus to the skin over the suspected nerve compression point, then bilaterally testing the strength of a specific muscle in the patient. Compression is then manifested by a transient loss of strength in the muscle on the affected side, while it is preserved on the healthy side. This loss of strength is transient and disappears after a few seconds. This test can be performed during a patient's clinical examination, with the physician assessing strength or, conversely, muscle collapse. However, while several articles have described the relevance of this test, as well as its sensitivity and specificity, no study has specifically investigated and measured this observed loss of eccentric muscle tone and its unilateral and transient nature, even though the phenomenon of CSP (cutaneous silent period) has been described. We therefore propose to analyze the myographic tracing obtained in patients diagnosed with unilateral carpal tunnel syndrome. A transient loss of muscle tone is expected by selective needle myography on the pathological side after cutaneous sensory stimulation of the wrist, while cutaneous sensory stimulation on the healthy side does not alter the tracings obtained by myography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 4, 2025
CompletedFirst Submitted
Initial submission to the registry
November 17, 2025
CompletedFirst Posted
Study publicly available on registry
November 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 4, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 5, 2026
CompletedNovember 25, 2025
November 1, 2025
6 months
November 17, 2025
November 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Evolution of the myographic tracings
Evolution of the myographic tracings (of the infraspinatus muscle) of the pathological arm immediately after ipsilateral stimuli compared to the basic tracings (before stimuli) of the pathological arm and evolution of the myographic tracings of the pathological arm 20 seconds after ipsilateral stimuli compared to the basic tracings (before stimuli) of the pathological arm.
one day
Study Arms (1)
Patient with unilateral carpal tunnel syndrome
EXPERIMENTALPatient with clinical unilateral carpal tunnel syndrome diagnosed by history, clinical examination and electromyography,
Interventions
This examination uses electrodes placed along the path of the median nerve to measure the transmission of nerve impulses (conduction studies). It is performed on both hands to compare the results.
The Scratch Collapse Test (SCT) is a neurocutaneous reflex used to detect peripheral nerve compression in nerve canal syndromes. It involves first performing a sensory stimulus on the skin at the suspected nerve compression site, then bilaterally testing the strength of a specific muscle in the patient. Compression is then manifested by a transient loss of strength in the muscle on the affected side, while it is preserved on the stimulated side.
Eligibility Criteria
You may qualify if:
- Patient over 18 years old
- Patient with clinical unilateral carpal tunnel syndrome diagnosed by history, clinical examination and electromyography,
- Patient who has been informed and has given their free, informed, and written consent,
- Patient affiliated with or beneficiary of a social security scheme.
You may not qualify if:
- Other associated canal syndrome on either side (ulnar, defilement, lacertus),
- Rotator cuff pathology, insufficiency or rupture of the infraspinatus,
- Associated cervical pathology,
- Neuropathy, central or peripheral neurological disease,
- Diabetic patient,
- Patient with cognitive impairments that prevent the understanding of the study information,
- Refusal to participate in the study,
- Pregnant, parturient, or breastfeeding woman,
- Patient under legal protection,
- Patient not receiving health protection,
- Protected patient: adult under guardianship, curatorship, or other legal protection, deprived of liberty by judicial or administrative decision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Elsanlead
Study Sites (1)
Clinique de l'Ormeau
Tarbes, 65000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2025
First Posted
November 25, 2025
Study Start
November 4, 2025
Primary Completion
May 4, 2026
Study Completion
May 5, 2026
Last Updated
November 25, 2025
Record last verified: 2025-11